Top

Published in:

01-12-2008 | 2008 ssat other

Pyogenic Complications of Crohn’s Disease, Evaluation, and Management

Author: James W. Fleshman

Published in: Journal of Gastrointestinal Surgery | Issue 12/2008

Abstract

The principal by which treatment of pyogenic complications anorectal disease is guided should rely heavily on small procedure with medical management of rectal disease and limitation of proctectomy. Management of pyogenic complications of abdominal Crohn’s by an elective approach after percutanea drainage of abscess and nutritional repletion should prevent long term complication even when its patient is receiving immune suppressive therapy.

Strong SA. Surgery for Crohn’s disease. In ASCRS textbook of colon and rectal surgery, Wolff BG, Fleshman JW, Beck DE, et al eds. New York: Springer, pp. 584–600.

Caprioli F, Losco A, Vigano C, et al. Computer-assisted evaluation of perianal fistula activity by means of anal ultrasound in patients with Crohn’s disease. Am J Gastroenterol. 2006;101:1551–1558. doi:10.1111/j.1572-0241.2006.00561.x.PubMedCrossRef

Schwartz DA, White CM, Wise PE, et al. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn’s perianal fistulas. Inflamm Bowel Dis. 2005;11:727–732. doi:10.1097/01.MIB.0000172811.57242.18.PubMedCrossRef

Thornton M, Solomon MJ. Long-term indwelling seton for complex anal fistulas in Crohn’s disease. Dis Colon Rectum. 2005;48:459–463. doi:10.1007/s10350-004-0830-6.PubMedCrossRef

Buchanan GN, Owen HA, Torkington J, et al. Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula. Br J Surg. 2004;91:476–480. doi:10.1002/bjs.4466.PubMedCrossRef

Rasul I, Wilson SR, MacRae H, et al. Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn’s disease. Am J Gastroenterol. 2004;99:82–88. doi:10.1046/j.1572-0241.2003.04009.x.PubMedCrossRef

Hyder SA, Travis SP, Jewell DP, et al. Fistulating anal Crohn’s disease: results of combined surgical and infliximab treatment. Dis Colon Rectum. 2006;49:1837–1841. doi:10.1007/s10350-006-0656-5.PubMedCrossRef

van der Hagen SJ, Baeten CG, Soeters PB, et al. Anti-TNF alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn’s disease: a preliminary report. Dis Colon Rectum. 2005;48:758–767. doi:10.1007/s10350-004-0828-0.PubMedCrossRef

Loungnarath R, Dietz DW, Mutch MG, et al. Fibrin glue treatment of complex anal fistulas has low success rate. Dis Colon Rectum. 2004;47:432–436. doi:10.1007/s10350-003-0076-8.PubMedCrossRef

10.

Whiteford MH, Kilkenny J, Hyman N, et al. Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised). Dis Colon Rectum. 2005;48:1337–1342. doi:10.1007/s10350-005-0055-3.PubMedCrossRef

11.

Mueller MH, Geis M, Glatzle J, et al. Risk of fecal diversion in complicated perianal Crohn’s disease. J Gastrointest Surg. 2007;11:529–537. doi:10.1007/s11605-006-0029-3.PubMedCrossRef

12.

Harisinghani MG, Gervais DA, Maher MM, et al. Transgluteal approach for percutaneous drainage of deep pelvic abscesses: 154 cases. Radiology. 2003;228:701–705. doi:10.1148/radiol.2283020924.PubMedCrossRef

13.

Golfieri R, Cappelli A, Giampalma E, et al. CT-guided percutaneous pelvic abscess drainage in Crohn’s disease. Tech Coloproctology. 2006;10:99–105. doi:10.1007/s10151-006-0260-7.CrossRef

14.

Poritz LS, Koltun WA. Percutaneous drainage and ileocolectomy for spontaneous intraabdominal abscess in Crohn’s disease. J Gastrointest Surg. 2007;12:204–208. doi:10.1007/s11605-006-0030-x.CrossRef

15.

Gutierrez A, Lee H, Sands BE. Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn’s disease. Am J Gastroenterol. 2006;101:2283–2289. doi:10.1111/j.1572-0241.2006.00757.x.PubMedCrossRef

16.

Neufeld D, Keidar A, Gutman M, et al. Abdominal wall abscesses in patients with Crohn’s disease: clinical outcome. J Gastrointest Surg. 2006;10:445–449. doi:10.1016/j.gassur.2005.06.004.PubMedCrossRef

17.

Alves A, Panis Y, Bouhnik Y, et al. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum. 2007;50:331–336. doi:10.1007/s10350-006-0782-0.PubMedCrossRef

18.

Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum. 2007;50:1968–1986. doi:10.1007/s10350-007-0279-5.PubMedCrossRef

19.

Sands BE, Blank MA, Diamond RH, et al. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn’s disease: results from the ACCENT II study. Aliment Pharmacol Ther. 2006;23:1127–1136. doi:10.1111/j.1365-2036.2006.02878.x.PubMedCrossRef

20.

Colombel J, Loftus E, Tremaine W, et al. Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol. 2004;99:878–883. doi:10.1111/j.1572-0241.2004.04148.x.PubMedCrossRef

21.

Evans JP, Steinhart AH, Cohen Z, et al. Home total parenteral nutrition: an alternative to early surgery for complicated inflammatory bowel disease. J Gastrointest Surg. 2003;7:562–566. doi:10.1016/S1091-255X(02)00132-4.PubMedCrossRef

22.

Alves A, Panis Y, Bouhnik Y, et al. Factors that predict conversion in 69 consecutive patients undergoing laparoscopic ileocecal resection for Crohn’s disease: a prospective study. Dis Colon Rectum. 2005;48:2302–2308. doi:10.1007/s10350-005-0190-x.PubMedCrossRef

23.

Regan JP, Salky BA. Laparoscopic treatment of enteric fistulas. Surg Endosc. 2004;18:252–254. doi:10.1007/s00464-003-8904-4.PubMedCrossRef

24.

Wu JS, Meyer K, Birnbaum EH, et al. Laparoscopic-assisted ileocolic resections in Crohn’s patients: are abscesses, phlegmons, or recurrent disease contraindications? Gastroenterology. 1996;110:1427.

25.

Lowney JK, Dietz DW, Birnbaum EH, et al. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn’s disease compared to conventional surgery? A long term follow up study. Dis Colon Rectum. 2006;49:58–63. doi:10.1007/s10350-005-0214-6.PubMedCrossRef

Title: Pyogenic Complications of Crohn’s Disease, Evaluation, and Management
Author: James W. Fleshman
Publication date: 01-12-2008
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 12/2008
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-008-0673-x

At a glance: The STEP trials

Springer Medicine

Pyogenic Complications of Crohn’s Disease, Evaluation, and Management

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2008

Distal Pancreatectomy is Not Associated with Increased Perioperative Morbidity when Performed as Part of a Multivisceral Resection

The Azygos Vein: to Resect or Not?

Zenker’s Diverticula: Feasibility of a Tailored Approach Based on Diverticulum Size

Letter to the Editor—Early ERCP for Gallstone Pancreatitis: For Whom and When?

Laparoscopic Repair of Giant Paraesophageal Hernia Results in Long-Term Patient Satisfaction and a Durable Repair

Clinicopathological Feature and Surgical Outcome of Choledochal Cyst in Different Age Groups: The Implication of Surgical Timing